Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics

Clinical Pharmacology and Therapeutics

Volumn 99, Issue 6, 2016, Pages 585-587

  Bruner, S D ^a   Jobin, C ^b,c  

^a University of Florida   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACTERIA; ARTICLE; CANCER GROWTH; CARCINOGENESIS; ENTERITIS; FUSOBACTERIA; HOMEOSTASIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEOBACTERIA; ULCERATIVE COLITIS; BACTERIUM; COLORECTAL NEOPLASMS; INFLAMMATORY BOWEL DISEASES; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA;

BACTERIA; CARCINOGENESIS; COLORECTAL NEOPLASMS; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA;

EID: 84975706909     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.348     Document Type: Article

References (5)

1. Schwabe, R.F., Jobin, C. The microbiome and cancer. Nat. Rev. 13, 800-812 (2013).
2. Garrett, W.S. Cancer and the microbiota. Science 348, 80-86 (2015).
3. Sears, C.L., Geis, A.L., Housseau, F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J. Clin. Investig. 124, 4166-4172 (2014).
4. Nougayrede, J.P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848-851 (2006).
5. Yang, Y., Jobin, C. Microbial imbalance and intestinal pathologies: connections and contributions. Dis. Model. Mech. 7, 1131-1142 (2014).